Orthox Overview
- Founded
- 2008
- Status
- Private
- Employees
- 18
- Latest Deal Type
- Series A
- Latest Deal Amount
- $4.34M
- Investors
- 11
Orthox General Information
Description
Developer of tissue regenerative implants intended to address large injuries to knee cartilage in which early osteoarthritis (OA) may be present. The company's tough, resilient, low friction, hydrogel implants emulate cartilage tissue and rapidly restore knee function while allowing the body's own cells to grow through and integrate with the device, enabling patients to return to a fully active and pain-free lifestyle.
Contact Information
- 66 Innovation Drive
- Milton Park
- Abingdon OX14 4RQ
- England, United Kingdom
Orthox Timeline
Orthox Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 19. Later Stage VC (Series A) | 09-Feb-2022 | $4.34M | 000.00 | Completed | Clinical Trials - General | |
| 18. Accelerator/Incubator | 01-Jun-2021 | 00000 | 00.00 | Completed | Clinical Trials - Phase 1 | |
| 17. Later Stage VC | 01-Dec-2020 | 00000 | 00.00 | Completed | Pre-Clinical Trials | |
| 16. Later Stage VC | 01-Sep-2020 | 00000 | 00.00 | Completed | Clinical Trials - Phase 1 | |
| 15. Grant | 01-Jul-2020 | 00.000 | 00.000 | Completed | Clinical Trials - Phase 1 | |
| 14. Accelerator/Incubator | 01-Jun-2020 | 00.000 | 00.000 | Completed | Clinical Trials - Phase 1 | |
| 13. Grant | 01-Jan-2020 | 00000 | 00.000 | Completed | Clinical Trials - General | |
| 12. Grant | 01-Oct-2019 | 00000 | 00.000 | Completed | Clinical Trials - General | |
| 11. Grant | 01-Oct-2018 | $1.57M | $8.54M | Completed | Clinical Trials - General | |
| 10. Later Stage VC | 01-Aug-2018 | $1.98M | $8.54M | Completed | Clinical Trials - General |
Orthox Patents
Orthox Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200205986-A1 | Implantable tissue repair devices and methods for manufacturing the same | Pending | 05-Jun-2017 | 00000000000 | |
| AU-2018281970-B2 | Implantable tissue repair devices and methods for manufacturing the same | Active | 05-Jun-2017 | 00000000000 | 0 |
| EP-3634318-A1 | Implantable tissue repair devices and methods for manufacturing the same | Pending | 05-Jun-2017 | 00000000000 | |
| GB-201708909-D0 | Implantable tissue repair devices and methods for manufacturing the same | Ceased | 05-Jun-2017 | 00000000000 | |
| AU-2018281970-A1 | Implantable tissue repair devices and methods for manufacturing the same | Granted | 05-Jun-2017 | A61F2/30756 |
Orthox Executive Team (4)
Orthox Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| Allan Ritchie | Orthox | Board Member | 000 0000 |
| David Knight | Orthox | Board Member | 000 0000 |
| Friedrich Vollrath | Self | Board Member | 000 0000 |
| Harry Sykes | Self | Board Member | 000 0000 |
| James Mallinson | Oxford Spin-out Equity Management | Chairman | 000 0000 |
Orthox Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialOrthox Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Additio Investment Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
| MedTech Innovator | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| Perivoli Innovations Trust | Venture Capital | Minority | 000 0000 | 000000 0 | |
| EIT Health | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| EIC Accelerator | Accelerator/Incubator | 000 0000 | 000000 0 |